Enliven Therapeutics, Inc 10-K for FY2023
Enliven Therapeutics, Inc. (ELVN)
10-K
2024-03-14
For: 2023-12-31
View Original
Added on
April 07, 2026
About this 10-K
Enliven Therapeutics, Inc filed this 10-K on March 14, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $71.58M
- compared with a net loss of $37.66M a year earlier
- Diluted EPS
- -$2.01
- compared with -$12.05 a year earlier